Management of persistent juvenile angiofibroma after endoscopic resection: Analysis of a single institution series of 74 patients

Abstract

Management of persistent juvenile angiofibroma (pJA) after transnasal endoscopic resection is controversial. To better understand its behavior, optimize treatment, and minimize morbidity, we report our experience in pJA focusing on follow‐up strategies and disease progression.